Literature DB >> 24714242

Intestinal spirochetosis: a "fuzzy" entity.

Srikantaiah Manjunath1, Andrew Thompson2.   

Abstract

Entities:  

Year:  2012        PMID: 24714242      PMCID: PMC3959405     

Source DB:  PubMed          Journal:  Ann Gastroenterol        ISSN: 1108-7471


× No keyword cloud information.
The presence of spirochetes in the human bowel has been recognized for over a century. Harland in 1967 described spirochetes on electron microscopy of rectal biopsies in a man with chronic diarrhea, and coined the term intestinal spirochetosis (IS) [1]. We report two cases of IS followed by review of literature. A 23-year-old male homosexual presented with diarrhea for 9 months but no blood. The routine hematology, biochemistry and inflammatory markers were normal. A rigid sigmoidoscopy showed normal mucosa. The biopsies revealed mucosa covered with fuzzy brush border, 2-3 μm thick and staining blue with hematoxylin (Fig. 1). His symptoms improved with a course of metronidazole.
Figure 1

Colonic biopsy showing 2-3 µm thick hematoxylin stained spirochetes lining the mucosa forming a false brush border

Colonic biopsy showing 2-3 µm thick hematoxylin stained spirochetes lining the mucosa forming a false brush border A 16-year-old girl presented with sudden onset pain, fever, vomiting associated with tenderness and guarding in right iliac fossa. The white cell count was 12800 /mm3 (normal 4-11,000) and a C-reactive protein of 36 mg/dL (normal less than 6). She underwent laparoscopic appendicectomy. The resected specimen showed inflamed appendix with neutrophilic infiltrates. The mucosa was covered with hematoxylin-stained fuzzy border. IS is a well-recognized entity. Prevalence rates are highly variable but in general, the rates are inversely related to standards of living. Incidence varies throughout the world from 2-10% in Western Europe to 30% in Chicago to nearly 100% in western Africa [2]. It is also more common in homosexuals and HIV-infected patients and prevalence of up to 54% has been observed in homosexual men [3]. Human IS is mainly caused by two species of spirochetes named Brachyspira aalborgi (B. aalborgi) and Brachyspira pilosicoli. The clinical presentation in humans varies from being asymptomatic to common symptoms of abdominal pain (46%), diarrhea (51%), alternating diarrhea and constipation (13%) and rectal bleeding [4]. Abdominal pain can mimic acute appendicitis. The invasive disease is very rare unless the patient is immunocompromised [3]. The diagnosis of IS is by histological examination of the biopsy specimens. The characteristic appearance of a dense basophilic band, 2-3 μm thick, along the colonic surface is diagnostic. The organisms can be demonstrated by electron microscopy. It is difficult to culture the organisms due to fastidious and slow growth, especially B. aalborgi [5]. IS can involve the entire colon, appendix and even terminal ileum. In a large study spirochetes were found in 12.3% of appendices removed from patients clinically suspected to have acute appendicitis but whose appendices were histologically normal. However, only 0.7% with histologically confirmed appendicitis did show spirochetes in their appendices (P<0.05) [6]. Our second case belongs to this group. The clinical importance of IS remains unclear and controversial. Symptoms do not seem to correlate with the extent of colonic involvement or even clearance or persistence of the organisms. There is inadequacy of evidence based information regarding this clinical entity. The management consensus seems to lean towards a ‘wait and watch’ approach with the antibiotic treatment reserved for patients with persistent symptoms without other demonstrable pathology, especially in high-risk groups.
  6 in total

1.  Intestinal spirochetosis and chronic watery diarrhea: clinical and histological response to treatment and long-term follow up.

Authors:  Maria Esteve; Antonio Salas; Fernando Fernández-Bañares; Josep Lloreta; Meritxell Mariné; Clara Isabel Gonzalez; Montserrat Forné; Jaume Casalots; Rebeca Santaolalla; Jorge Carlos Espinós; Mohammed Arif Munshi; David John Hampson; Josep Maria Viver
Journal:  J Gastroenterol Hepatol       Date:  2006-08       Impact factor: 4.029

2.  Intestinal spirochetosis of the vermiform appendix.

Authors:  R Henrik-Nielsen; F A Lundbeck; P S Teglbjaerg; P Ginnerup; K Hovind-Hougen
Journal:  Gastroenterology       Date:  1985-04       Impact factor: 22.682

3.  Intestinal spirochaetosis.

Authors:  W A Harland; F D Lee
Journal:  Br Med J       Date:  1967-09-16

4.  Human intestinal spirochetosis: analysis of the symptoms of 209 patients.

Authors:  Bianca Weisheit; Birgit Bethke; Manfred Stolte
Journal:  Scand J Gastroenterol       Date:  2007-12       Impact factor: 2.423

5.  Assessment of the clinical significance of intestinal spirochaetosis.

Authors:  S O'Donnell; N Swan; P Crotty; D Sangster; C O'Morain
Journal:  J Clin Pathol       Date:  2008-08-04       Impact factor: 3.411

6.  Intestinal spirochetosis in eight pediatric patients from Southern Sweden.

Authors:  Lars Marthinsen; Roger Willén; Birgitta Carlén; Eva Lindberg; Gunilla Värendh
Journal:  APMIS       Date:  2002-08       Impact factor: 3.205

  6 in total
  1 in total

Review 1.  Human intestinal spirochetosis, irritable bowel syndrome, and colonic polyps: A systematic review and meta-analysis.

Authors:  Kening Fan; Guy D Eslick; Prema M Nair; Grace L Burns; Marjorie M Walker; Emily C Hoedt; Simon Keely; Nicholas J Talley
Journal:  J Gastroenterol Hepatol       Date:  2022-04-24       Impact factor: 4.369

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.